Phys Written Answers · general-medicine
Anaphylaxis — Written Clinical Reasoning
DCE written preparation: structured clinical reasoning for anaphylaxis scenarios — bee sting with airway compromise, and refractory anaphylaxis in a beta-blocked patient.
On this page & tools
Target exams
Model answer — Part A: bee sting with airway compromise
Recognise and state the diagnosis. Acute onset of skin involvement (urticaria) plus respiratory compromise (stridor, wheeze) and hypotension after a known trigger — this satisfies the NIAID/FAAN criteria and is grade 3 (severe) anaphylaxis; the stridor makes airway the first threat [1] [2].
First drug, first dose, exact route. Immediate adrenaline 0.5 mg (0.5 mL of 1:1000) intramuscularly into the anterolateral thigh — before IV access, before any other drug. The intramuscular thigh route gives faster, higher peak levels than subcutaneous injection, and undiluted IV bolus adrenaline in a perfusing patient is dangerous [1] [3].
Position and support. Lie him flat with legs elevated and do not allow standing or walking; high-flow oxygen; wide-bore IV access with monitoring; call for senior airway and ICU help early because tongue swelling with stridor can progress to a difficult intubation [2].
Repeat and fill. Repeat adrenaline every 5 minutes while airway, breathing or circulatory features persist; give rapid IV crystalloid, 1–2 litres in the adult, for the vasodilated, leaking circulation [1].
Second-line agents — named, dosed and demoted. An H1-antihistamine for cutaneous symptoms once resuscitation is underway; a corticosteroid on the biphasic rationale; nebulised salbutamol for residual bronchospasm. State explicitly that none of these treats the acute phase and none has adequate trial evidence — adrenaline is the treatment [7].
Model answer — Part B: refractory anaphylaxis on beta-blockers
Frame it. Ongoing hypotension despite three IM adrenaline doses is refractory anaphylaxis; her beta-blocker is both worsening the reaction and blunting adrenaline's effect, which explains the paradoxical bradycardia [4] [5].
Escalation. Urgent ICU involvement and arterial-level monitoring; move from repeated boluses to a titrated adrenaline infusion; continue judicious crystalloid with reassessment; prepare for definitive airway management if any upper-airway feature emerges [1] [5].
The key pharmacology. Glucagon 1–5 mg IV bolus followed by an infusion at 5–15 micrograms per minute — it stimulates adenylate cyclase via its own receptor, bypassing the blocked beta-receptor; this is the specific antidote-answer for beta-blocked refractory anaphylaxis [4]. Add a second vasopressor (noradrenaline or vasopressin) if vasoplegia dominates [5].
Investigation. Acute serum tryptase within 1–2 hours of onset and a baseline after 24 hours, interpreted as a delta; document the reaction to contrast precisely for the radiology record [6].
Discharge. Observe overnight given severity and multi-dose requirement; discharge with two adrenaline autoinjectors and training, a written action plan, specialist allergy referral, and a medication review that explicitly weighs her beta-blocker indication against future reaction risk — a shared, documented decision [6].
References
- [1]Muraro A, Roberts G, Worm M, et al. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology Allergy, 2014.PMID 24909803
- [2]Cardona V, Ansotegui IJ, Ebisawa M, et al. World allergy organization anaphylaxis guidance 2020 World Allergy Organ J, 2020.PMID 33204386
- [3]Simons FE, Gu X, Simons KJ Epinephrine absorption in adults: intramuscular versus subcutaneous injection J Allergy Clin Immunol, 2001.PMID 11692118
- [4]Zaloga GP, DeLacey W, Holmboe E, et al. Glucagon reversal of hypotension in a case of anaphylactoid shock Ann Intern Med, 1986.PMID 3717811
- [5]Francuzik W, Dölle-Bierke S, Knop M, et al. Refractory Anaphylaxis: Data From the European Anaphylaxis Registry Front Immunol, 2019.PMID 31749797
- [6]Campbell RL, Li JT, Nicklas RA, et al. Emergency department diagnosis and treatment of anaphylaxis: a practice parameter Ann Allergy Asthma Immunol, 2014.PMID 25466802
- [7]Choo KJ, Simons E, Sheikh A Glucocorticoids for the treatment of anaphylaxis: Cochrane systematic review Allergy, 2010.PMID 20584003